PMID: 7082530May 1, 1982Paper

Assay and characterisation of debrisoquine 4-hydroxylase activity of microsomal fractions of human liver

British Journal of Clinical Pharmacology
G C KahnD S Davies

Abstract

1 A method for the assay of debrisoquine 4-hydroxylase activity in vitro by microsomal fractions of human liver is described. The assay utilises gas chromatography-mass spectrometry with d9-4-hydroxydebrisoquine as internal standard. 2 The limit of detection of 4-hydroxydebrisoquine was 2 ng ml -1 and the coefficient of variation was 4.4%. 3 Debrisoquine 4-hydroxylase activity was linear with protein to concentrations above 2.1 mg ml -1 and with incubation times of at least 15 min. 4 Debrisoquine 4-hydroxylase is a microsomal enzyme with a requirement for NADPH. Activity was inhibited by carbon monoxide. It is concluded that the activity is catalysed by cytochrome P-450. 5 In three samples of human liver the mean value for Vmax of debrisoquine 4-hydroxylase activity was 69.9 +/- 14.3 pmol mg -1 min -1 and for Km it was 130 +/- 24 microM. 6 The only variable from smoking status, alcohol ingestion, sex of the patients, source of liver sample and presence of liver disease that had a significant effect on 4-hydroxylation of debrisoquine was the presence of liver disease. This was associated with a decrease in enzyme activity.

References

May 1, 1979·The Journal of Pharmacy and Pharmacology·L A WakileR L Smith
Sep 17, 1977·Lancet·A MahgoubR L Smith
Oct 1, 1977·Lancet·G T TuckerA J Smith
Sep 2, 1978·British Medical Journal·T P SloanR L Smith
Mar 1, 1979·British Journal of Clinical Pharmacology·J R IdleR L Smith
Nov 1, 1979·Clinical Pharmacology and Therapeutics·N M WoolhouseR L Smith
Sep 1, 1979·European Journal of Clinical Pharmacology·M EichelbaumH J Dengler
Jul 1, 1979·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·I KitchenR T Williams
Jul 1, 1976·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J G AllenT R Marten
Jan 1, 1976·Biochemical Society Transactions·M AngeloR L Smith
May 24, 1980·Lancet·R R ShahR L Smith
Apr 4, 1981·Lancet·R H WaringR L Smith
Jan 1, 1980·British Journal of Clinical Pharmacology·A R BoobisD S Davies
Jan 1, 1981·British Journal of Clinical Pharmacology·D S DaviesA R Boobis
Apr 1, 1980·Clinical Pharmacology and Therapeutics·T InabaW Kalow
Feb 1, 1980·European Journal of Clinical Pharmacology·L BertilssonH U Schulz
Apr 1, 1981·Clinical Pharmacology and Therapeutics·T P SloanR L Smith

Citations

Apr 1, 1985·Klinische Wochenschrift·M S Lennard
Jul 12, 2008·Archives of Toxicology·Olavi PelkonenHannu Raunio
Jan 1, 1987·Pharmacology & Therapeutics·A R BoobisD S Davies
Apr 1, 1986·Clinical Biochemistry·W Kalow
Sep 21, 2007·Expert Opinion on Drug Delivery·Marta RoldoJohn Tsibouklis
Feb 27, 2004·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·N J ProctorA Rostami-Hodjegan
Apr 1, 1989·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·F BerthouA Guillouzo
Jul 1, 1997·Biochemical Pharmacology·D A AdamsA R Boobis
Sep 1, 1989·British Journal of Clinical Pharmacology·D LarreyD Pessayre
Jun 1, 1985·British Journal of Clinical Pharmacology·A R BoobisD S Davies
Nov 1, 1982·British Journal of Clinical Pharmacology·B K Park
Jul 9, 2010·Drug Metabolism and Pharmacokinetics·Hidetaka KamimuraTakashi Usui
Jan 1, 1986·CRC Critical Reviews in Biochemistry·M Adesnik, M Atchison
Jan 1, 1986·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·P L IversenE Bresnick
Sep 1, 1984·Alcoholism, Clinical and Experimental Research·P L LanthierM Y Morgan
Jun 1, 1984·European Journal of Clinical Investigation·E I MinderU A Meyer
Jul 16, 2010·The Biochemical Journal·Ann K Daly
May 23, 2002·The Journal of Pharmacology and Experimental Therapeutics·Camille P GranvilFrank J Gonzalez
Jan 1, 1984·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·A R Boobis, D S Davies
Dec 1, 1987·The Journal of Pharmacy and Pharmacology·M E McManusP J Wirth

Related Concepts

Tendor
Mixed Function Oxygenases
Microsomes, Liver
Cytochrome P-450 CYP2D6

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Glut1 Deficiency

Glut1 deficiency, an autosomal dominant, genetic metabolic disorder associated with a deficiency of GLUT1, the protein that transports glucose across the blood brain barrier, is characterized by mental and motor developmental delays and infantile seizures. Follow the latest research on Glut1 deficiency with this feed.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Laryngeal Neoplasms

Laryngeal Neoplasms occur in the Larynx and are typically associated with smoking and alcohol consumption. Discover the latest research on Laryngeal Neoplasms here.

Cell Atlas Along the Gut-Brain Axis

Profiling cells along the gut-brain axis at the single cell level will provide unique information for each cell type, a three-dimensional map of how cell types work together to form tissues, and insights into how changes in the map underlie health and disease of the GI system and its crosstalk with the brain. Disocver the latest research on single cell analysis of the gut-brain axis here.